SGLT2 inhibition, glucose transport and peritoneal dialysis: Finding the sweet spot

Perit Dial Int. 2023 Mar;43(2):115-118. doi: 10.1177/08968608231161178.

Authors

Vikas S Sridhar¹, Donald J Fraser²

Affiliations

¹ Division of Nephrology, Department of Medicine, Toronto General Hospital, University of Toronto, Ontario, Canada.
² Wales Kidney Research Unit, School of Medicine, College of Biomedical and Life Sciences, Heath Park, Cardiff, UK.

PMID: 37013683
DOI: 10.1177/08968608231161178

No abstract available

Publication types

Editorial

MeSH terms

Biological Transport
Dialysis Solutions
Glucose* / metabolism
Humans
Peritoneal Dialysis*
Peritoneum / metabolism
Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use

Substances

Dialysis Solutions
Glucose
Sodium-Glucose Transporter 2 Inhibitors